Preventing Both EBV Infection and EBV‐Associated Diseases: Advances in Vaccine Research
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.70961 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Guo-Long Bu und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Cli…. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Herpesvirus 4, Human, Herpesvirus Vaccines, Viral Vaccines. Die Arbeit nennt 101 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project.
Abstract (Originalsprache)
Epstein‐Barr Virus (EBV), the first identified human oncovirus, is associated with a variety of human malignancies. It is estimated that more than 90% of the adults worldwide are infected with EBV. In 2020, EBV‐attributable cancers accounted for approximately 1.3%–1.9% of the global cancer burden. Currently, no licensed vaccine against EBV is available for clinical use. The success of COVID‐19 vaccines has provided a framework and momentum for novel efforts against EBV, accelerating vaccine research and yielding several promising candidates, some of which have entered clinical trials. These advances are expected to contribute substantially to preventing EBV infection and managing EBV‐associated diseases. In this review, we assess the current landscape and recent advances in EBV vaccine research, summarizing progress across different vaccine platforms. This overview intends to provide a theoretical foundation for the future development and translational application of EBV vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center…
- Department of Molecular Diagnostics, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- China Postdoctoral Science Foundation
- National Basic Research Program of China
Zitieren
APA
Bu, G. L., Chen, L. N., Wu, P. H., Zeng, M. S., & Zhong, Q. (2026). Preventing Both EBV Infection and EBV‐Associated Diseases: Advances in Vaccine Research. Journal of Medical Virology. https://doi.org/10.1002/jmv.70961
Vancouver
Bu GL, Chen LN, Wu PH, Zeng MS, Zhong Q. Preventing Both EBV Infection and EBV‐Associated Diseases: Advances in Vaccine Research. Journal of Medical Virology. 2026. doi:10.1002/jmv.70961
BibTeX
@article{Bu2026,
author = {Bu, Guo-Long and Chen, Li-Na and Wu, Pei-Huang and Zeng, Mu-Sheng and Zhong, Qian},
title = {Preventing Both EBV Infection and EBV‐Associated Diseases: Advances in Vaccine Research},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.70961}
}
EUVIMED